. . . . . . . . . . . . . . "tscript(p(MGI:Cebpa)) -> path(MESHD:Hypertrophy)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Attempts to extend these findings in vivo, however, were initially hampered by perinatal lethality of homozygote C/EBPa null mice, which perish due to hypoglycemia secondary to a failure of hepatic gluconeogenesis [13]. Two different groups subsequently developed ways to work around this problem. One group expressed C/EBPb from the endogenous C/EBPa locus (so-called C/EBPb/b mice) [14]. This rescued the hepatic phenotype, presumably because the requirement for a C/EBP in liver is not restricted to the C/EBPa isoform. In white fat, however, C/EBPa function could not be replaced by C/EBPb, and these animals had small fat pads with reduced lipid content per cell." . . "Selventa" . . . . "2014-07-03T14:30:35.836+02:00"^^ . . .